Study title: Evaluation of Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non Hormonal Contraceptive Users
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Pathological Conditions, Signs and Symptoms [C23] | |||||
Brands: Please see report, Please see report | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: MEDROXYPROGESTERONE ACETATE | |||||
ATC code: | |||||
Document link: A6791022 PhRMA Web Synopsis.pdf | |||||
Document date: 2013-06-04 | |||||
Study number: A6791022 (Z-5400-0261) | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |